These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging. Esposito A; De Cobelli F; Perseghin G; Pieroni M; Belloni E; Mellone R; Canu T; Gentinetta F; Scifo P; Chimenti C; Frustaci A; Luzi L; Maseri A; Maschio AD Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417 [TBL] [Abstract][Full Text] [Related]
7. [Evaluation of myocardial energy metabolism by 31 P-magnetic resonance spectroscopy in patients with hypertrophic cardiomyopathy versus healthy individuals]. Mazaev VV; Stukalova OV; Ternovoĭ SK; Chazova IE Vestn Rentgenol Radiol; 2012; (6):8-12. PubMed ID: 23520935 [TBL] [Abstract][Full Text] [Related]
8. Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy. de Roos A; Doornbos J; Luyten PR; Oosterwaal LJ; van der Wall EE; den Hollander JA J Magn Reson Imaging; 1992; 2(6):711-9. PubMed ID: 1446116 [TBL] [Abstract][Full Text] [Related]
9. 31P nuclear magnetic resonance spectroscopy: a noninvasive tool to monitor metabolic abnormalities in left ventricular hypertrophy in human. Jung WI; Dietze GJ Am J Cardiol; 1999 Jun; 83(12A):19H-24H. PubMed ID: 10750582 [TBL] [Abstract][Full Text] [Related]
10. Influence of aging or left ventricular hypertrophy on the human heart: contents of phosphorus metabolites measured by 31P MRS. Okada M; Mitsunami K; Inubushi T; Kinoshita M Magn Reson Med; 1998 May; 39(5):772-82. PubMed ID: 9581609 [TBL] [Abstract][Full Text] [Related]
11. (31)P magnetic resonance spectroscopy to measure in vivo cardiac energetics in normal myocardium and hypertrophic cardiomyopathy: Experiences at 3T. Shivu GN; Abozguia K; Phan TT; Ahmed I; Henning A; Frenneaux M Eur J Radiol; 2010 Feb; 73(2):255-9. PubMed ID: 19056193 [TBL] [Abstract][Full Text] [Related]
12. Feasibility of rapid-sequence 31P magnetic resonance spectroscopy in cardiac patients. Chida K; Otani H; Saito H; Nagasaka T; Kagaya Y; Kohzuki M; Zuguchi M; Shirato K Acta Radiol; 2005 Jul; 46(4):386-90. PubMed ID: 16134315 [TBL] [Abstract][Full Text] [Related]
13. Detection of metabolic abnormality in asynergic regions of ischemic human myocardium using 31P and 1H magnetic resonance spectroscopy. Nakae I; Mitsunami K; Yabe T; Inubushi T; Morikawa S; Matsuo S; Koh T; Horie M J Cardiovasc Magn Reson; 2004; 6(3):685-96. PubMed ID: 15347133 [TBL] [Abstract][Full Text] [Related]
14. Secchi F; Di Leo G; Petrini M; Spairani R; Alì M; Guazzi M; Sardanelli F Radiol Med; 2017 Apr; 122(4):265-272. PubMed ID: 28070839 [TBL] [Abstract][Full Text] [Related]
15. High-energy phosphate metabolism of the myocardium in normal subjects and patients with various cardiomyopathies--the study using ECG gated MR spectroscopy with a localization technique. Masuda Y; Tateno Y; Ikehira H; Hashimoto T; Shishido F; Sekiya M; Imazeki Y; Imai H; Watanabe S; Inagaki Y Jpn Circ J; 1992 Jun; 56(6):620-6. PubMed ID: 1625368 [TBL] [Abstract][Full Text] [Related]